tryptophan has been researched along with fluvoxamine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 11 (73.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Marek, KL; McCance-Katz, EF; Price, LH | 1 |
| Azorin, JM; Bovier, P; Jeanningros, R; Tissot, R; Widmer, J | 1 |
| Anderson, GM; Charney, DS; Delgado, PL; Heninger, GR; Price, LH | 1 |
| Bovier, P; Gaillard, JM; Tissot, R; Widmer, J | 1 |
| Alfano, M; Catalano, M; Lucca, A; Lucini, V; Smeraldi, E | 1 |
| Andersen, J; Arup, P; Bille, A; Jensen, HV; Jørgenson, S; Møller, SE; Olafsson, K | 1 |
| Artigas, F; Bel, N | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Artigas, F; Bel, N; Casanovas, JM; Romero, L | 1 |
| Catalano, M; Lucca, A; Lucini, V; Smeraldi, E | 1 |
| Bellodi, L; Bianchi, L; Conca, R; Erzegovesi, S; Lucca, A; Lucini, V | 1 |
| Alecci, M; Boscati, L; Bravin, S; Ferrara, A; Invernizzi, G; Mauri, MC; Zamberlan, F | 1 |
| Alvarez, E; Artigas, F; Bel, N; Celada, P; Ortiz, J; Pérez, V | 1 |
| Eguchi, F; Goda, Y; Kikura-Hanajiri, R; Matsushima, Y; Shirota, O | 1 |
1 review(s) available for tryptophan and fluvoxamine
| Article | Year |
|---|---|
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
3 trial(s) available for tryptophan and fluvoxamine
| Article | Year |
|---|---|
Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Desipramine; Double-Blind Method; Fluvoxamine; Humans; Oximes; Prolactin; Serotonin; Serotonin Antagonists; Time Factors; Tryptophan | 1989 |
Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor.
Topics: Adult; Aged; Amino Acids; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluvoxamine; Humans; Male; Middle Aged; Personality Inventory; Tryptophan | 1994 |
Fluvoxamine treatment of dementia: tryptophan levels.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amino Acids; Dementia, Multi-Infarct; Female; Fluvoxamine; Humans; Male; Tryptophan | 1993 |
11 other study(ies) available for tryptophan and fluvoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Serotonergic dysfunction in depression associated with Parkinson's disease.
Topics: Depressive Disorder; Fluvoxamine; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Parkinson Disease; Serotonin; Tryptophan | 1992 |
L-tyrosine and L-tryptophan membrane transport in erythrocytes and antidepressant drug choice.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Erythrocyte Membrane; Female; Fluvoxamine; Humans; Imipramine; Male; Mianserin; Middle Aged; Monoamine Oxidase Inhibitors; Oximes; Piperidines; Receptors, Adrenergic; Receptors, Serotonin; Tryptophan; Tyrosine | 1990 |
Evolution of red blood cell membrane transport and plasma level of L-tyrosine and L-tryptophan in depressed treated patients according to clinical improvement.
Topics: Adult; Aged; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Desipramine; Erythrocyte Membrane; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Oximes; Psychological Tests; Tryptophan; Tyrosine | 1988 |
Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats.
Topics: Animals; Brain; Cerebral Cortex; Fluvoxamine; Hydroxyindoleacetic Acid; Male; Microdialysis; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan | 1996 |
Adaptative changes of the serotonergic system after antidepressant treatments.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Clomipramine; Clorgyline; Fluvoxamine; Frontal Lobe; Hydroxyindoleacetic Acid; Imipramine; Microdialysis; Monoamine Oxidase Inhibitors; Piperidines; Pyrimidines; Raphe Nuclei; Rats; Serotonin; Stereotaxic Techniques; Tranylcypromine; Tryptophan | 1996 |
Predicting value of tryptophan/large neutral amino acids ratio on selective serotonin reuptake inhibitors.
Topics: Amino Acids; Antidepressive Agents; Biomarkers; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Tryptophan | 1996 |
Plasma tryptophan levels and tryptophan/neutral amino acid ratios in obsessive-compulsive patients with and without depression.
Topics: Adult; Depressive Disorder; Female; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Tryptophan | 1997 |
Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment.
Topics: Adult; Aged; Amino Acids; Antidepressive Agents, Second-Generation; Blood Platelets; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Reference Values; Tryptophan | 1998 |
Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments.
Topics: Adult; Antidepressive Agents; Blood Platelets; Clomipramine; Depressive Disorder; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Prognosis; Serotonin; Thiazepines; Tryptophan | 1998 |
Effects of Psilocybe argentipes on marble-burying behavior in mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Calcium Carbonate; Fluvoxamine; Hallucinogens; Male; Mice; Mice, Inbred ICR; Motor Activity; Psilocybe; Tryptophan | 2009 |